AETHLON MEDICAL INC PP&E Disclosure
| March 31, 2026 | March 31, 2025 | |||||||
| Furniture and office equipment, at cost | $ | 761,978 | $ | 1,112,648 | ||||
| Add: additions | 3,704 | – | ||||||
| Less: disposals | (14,628 | ) | (350,670 | ) | ||||
| Leasehold improvements | 893,131 | 893,131 | ||||||
| Gross property and equipment | 1,644,185 | 1,655,109 | ||||||
| Less: accumulated depreciation | (1,287,363 | ) | (978,889 | ) | ||||
| Fixed assets, net | $ | 356,822 | $ | 676,220 | ||||
Want the next AETHLON MEDICAL INC pp&e disclosure the moment it drops?
Set a Sentinel and we'll alert you the moment AETHLON MEDICAL INC's next filing hits EDGAR. No credit card, your email never gets sold.
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2026 | Jun 10, 2026 | Showing above |
| 2025 | Jun 26, 2025 | |
| 2024 | Jun 27, 2024 | |
| 2023 | Jun 28, 2023 | |
| 2022 | Jun 28, 2022 | |
| 2021 | Jun 24, 2021 | |
| 2020 | Jun 25, 2020 | |
| 2019 | Jul 1, 2019 | |
| 2018 | Jun 8, 2018 | |
| 2017 | Jun 28, 2017 | |
| 2016 | Jun 29, 2016 | |
About PP&E Disclosures
The PP&E disclosure details a company's physical asset base — land, buildings, machinery, and equipment — along with the depreciation methods and useful life assumptions that determine how these costs flow through the income statement. Capitalization policy thresholds reveal management's judgment on the boundary between expense and asset, directly affecting both reported earnings and asset values.
Key signals: changes in estimated useful lives or depreciation methods can materially shift reported earnings without any operational change. Compare capital expenditures against depreciation expense — when capex consistently trails depreciation, the asset base may be aging and underinvested. Watch for large asset impairments or write-downs that signal overvalued carrying amounts. Asset retirement obligations reveal future environmental or decommissioning costs that are often underappreciated. Compare PP&E intensity (PP&E-to-revenue) against industry peers to assess capital efficiency and competitive positioning.